Xenocor has filed a notice of an exempt offering of securities to raise $10,000,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Xenocor is raising $10,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Charles Decoster played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Xenocor
XENOCOR brings to market a revolutionary technology that can extend the benefits of minimally-invasive laparoscopic surgery to hundreds of millions of people worldwide. The FDA approved Xenoscope, is a singleuse, fog-free, HD laparoscopic imaging system, which can easily replace expensive, inflexible old school technology to deliver advanced quality surgical care virtually anywhere. Xenocor is a privately held corporation, based in Salt Lake City, UT.
To learn more about Xenocor, visit http://www.xenocor.com/
Contact:
Charles Decoster, Chief Executive Officer
435-680-9782
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.